Targeted attack on advanced bladder cancer shows promise in new trial

NCT ID NCT02365597

Ongoing Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This study tested a targeted drug called erdafitinib in people with advanced bladder cancer that has spread or cannot be removed by surgery and has specific genetic changes (FGFR alterations). The main goal was to see how well the drug shrinks tumors and controls the cancer. Researchers also looked at how safe the drug is and how it interacts with other common medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Study site

Sedona, Arizona, United States
Study site

Los Angeles, California, United States
Study site

Orange, California, United States
Study site

Sacramento, California, United States
Study site

Stanford, California, United States
Study site

Aurora, Colorado, United States
Study site

Washington D.C., District of Columbia, United States
Study site

Chicago, Illinois, United States
Study site

Iowa City, Iowa, United States
Study site

Louisville, Kentucky, United States
Study site

Minneapolis, Minnesota, United States
Study site

Omaha, Nebraska, United States
Study site

Las Vegas, Nevada, United States
Study site

New York, New York, United States
Study site

Charlotte, North Carolina, United States
Study site

Medford, Oregon, United States
Study site

Tualatin, Oregon, United States
Study site

Hershey, Pennsylvania, United States
Study site

Pittsburgh, Pennsylvania, United States
Study site

Myrtle Beach, South Carolina, United States
Study site

Nashville, Tennessee, United States
Study site

Dallas, Texas, United States
Study site

Denton, Texas, United States
Study site

Houston, Texas, United States
Study site

Hampton, Virginia, United States
Study site

Graz, Austria
Study site

Linz, Austria
Study site

Vienna, Austria
Study site

Aalst, Belgium
Study site

Brussels, Belgium
Study site

Charleroi, Belgium
Study site

Ghent, Belgium
Study site

Wilrijk, Belgium
Study site

Angers, France
Study site

Bordeaux, France
Study site

Caen Cédex 05, France
Study site

Dijon, France
Study site

Lyon, France
Study site

Nice, France
Study site

Nîmes, France
Study site

Paris, France
Study site

Saint-Herblain, France
Study site

Suresnes, France
Study site

Villejuif, France
Study site

Berlin, Germany
Study site

Erlangen, Germany
Study site

Essen, Germany
Study site

Freiburg im Breisgau, Germany
Study site

Göttingen, Germany
Study site

Greifswald, Germany
Study site

Hamburg, Germany
Study site

Hanover, Germany
Study site

Heidelberg, Germany
Study site

München, Germany
Study site

Münster, Germany
Study site

Regensburg, Germany
Study site

Straubing, Germany
Study site

Weiden/Opf, Germany
Study site

Bangalore, India
Study site

Kolkata, India
Study site

Mira Road (East), India
Study site

Nadiād, India
Study site

Beer Yaakov, Israel
Study site

Beersheba, Israel
Study site

Haifa, Israel
Study site

Kfar Saba, Israel
Study site

Petah Tikva, Israel
Study site

Tel Aviv, Israel
Study site

Chisinau, Moldova
Study site

Bucharest, Romania
Study site

Cluj-Napoca, Romania
Study site

Craiova, Romania
Study site

Iași, Romania
Study site

Barnaul, Russia
Study site

Moscow, Russia
Study site

Omsk, Russia
Study site

Pyatigorsk, Russia
Study site

Saint Petersburg, Russia
Study site

Ufa, Russia
Study site

Daejeon, South Korea
Study site

Goyang-si, South Korea
Study site

Incheon, South Korea
Study site

Seoul, South Korea
Study site

Badalona, Spain
Study site

Barcelona, Spain
Study site

Madrid, Spain
Study site

Málaga, Spain
Study site

Pamplona, Spain
Study site

Sabadell, Spain
Study site

Santander, Spain
Study site

Santiago de Compostela, Spain
Study site

Seville, Spain
Study site

Valencia, Spain
Study site

Taichung, Taiwan
Study site

Tainan, Taiwan
Study site

Taipei, Taiwan
Study site

Taoyuan District, Taiwan
Study site

Istanbul, Turkey (Türkiye)
Study site

Blackburn, United Kingdom
Study site

Dundee, United Kingdom
Study site

Essex, United Kingdom
Study site

London, United Kingdom
Study site

Metropolitan Borough of Wirral, United Kingdom
Study site

Plymouth, United Kingdom
Study site

Sutton, United Kingdom

Conditions

Explore the condition pages connected to this study.

UROTHELIAL CANCER